M.E.G. Naranjo
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
-
- Pharmaceutical studies and practices
- Pharmacological Effects and Toxicity Studies
Papers in
- Pharmacology 13
- Pharmacogenetics and Drug Metabolism 13
- Treatment of Major Depression 2
- Drug-Induced Hepatotoxicity and Protection 1
-
- Pharmaceutical studies and practices 2
- Co-authors
- A. López LLerena (14 shared papers)Eva Peñas‐Lledó (11 shared papers)Fernanda Rodrigues‐Soares (3 shared papers)Humberto Fariñas (2 shared papers)Marisol López (3 shared papers)Eduardo Tarazona‐Santos (2 shared papers)Ingrid Fricke-Galindo (2 shared papers)Fernando de Andrés (4 shared papers)
In The Last Decade
M.E.G. Naranjo
15 papers receiving 553 citations
Peers
Comparison fields: 5 of 69
- Pharmacology 378
- Pediatrics, Perinatology and Child Health 89
- Oncology 109
- Biological Psychiatry 10
- Pharmacology 64
Countries citing papers authored by M.E.G. Naranjo
This map shows the geographic impact of M.E.G. Naranjo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.E.G. Naranjo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.E.G. Naranjo more than expected).
Fields of papers citing papers by M.E.G. Naranjo
This network shows the impact of papers produced by M.E.G. Naranjo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.E.G. Naranjo. The network helps show where M.E.G. Naranjo may publish in the future.
Co-authors
The 25 scholars most cited alongside M.E.G. Naranjo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 134 | |
| 2 | 2014 | 128 | |
| 3 | 2014 | 55 | |
| 4 | 2015 | 52 | |
| 5 | 2012 | 41 | |
| 6 | 2014 | 27 | |
| 7 | 2014 | 26 | |
| 8 | 2016 | 26 | |
| 9 | 2017 | 22 | |
| 10 | 2013 | 15 | |
| 11 | 2014 | 13 | |
| 12 | 2013 | 11 | |
| 13 | 2016 | 10 | |
| 14 | 2012 | 4 | |
| 15 | 2013 | 3 |
About M.E.G. Naranjo
M.E.G. Naranjo is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health, Statistics and Probability, Oncology and Pharmacology, having authored 15 papers that have together received 567 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (13 papers), Drug Transport and Resistance Mechanisms (3 papers), Statistical Methods in Clinical Trials (2 papers), Treatment of Major Depression (2 papers), Pharmaceutical studies and practices (2 papers), Tryptophan and brain disorders (1 paper), HIV/AIDS drug development and treatment (1 paper) and Drug-Induced Hepatotoxicity and Protection (1 paper). The work is most often cited by research in Pharmacology (378 citations), Pediatrics, Perinatology and Child Health (89 citations), Oncology (109 citations), Biological Psychiatry (10 citations) and Pharmacology (64 citations). M.E.G. Naranjo has collaborated with scholars based in Spain, Mexico and Brazil. Frequent co-authors include A. López LLerena, Eva Peñas‐Lledó, Fernanda Rodrigues‐Soares, Humberto Fariñas, Marisol López, Eduardo Tarazona‐Santos, Ingrid Fricke-Galindo, Fernando de Andrés, Pedro Dorado and Blanca Patricia Lazalde-Ramos. Their work appears in journals such as The Pharmacogenomics Journal, Expert Opinion on Drug Metabolism & Toxicology, Journal of Psychiatric Research, European Archives of Psychiatry and Clinical Neuroscience and Molecular Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.